Thymic hypoplasia
| Thymic hypoplasia | |
|---|---|
| Synonyms | DiGeorge syndrome, 22q11.2 deletion syndrome |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Immunodeficiency, hypocalcemia, congenital heart defects |
| Complications | Infections, autoimmune disorders |
| Onset | Congenital |
| Duration | Lifelong |
| Types | N/A |
| Causes | Genetic mutation, chromosomal deletion |
| Risks | Family history, genetic predisposition |
| Diagnosis | Genetic testing, immunological assessment |
| Differential diagnosis | Severe combined immunodeficiency, CHARGE syndrome |
| Prevention | Genetic counseling |
| Treatment | Thymus transplant, calcium supplementation, cardiac surgery |
| Medication | Immunoglobulin therapy, antibiotics |
| Prognosis | Variable, depends on severity and treatment |
| Frequency | 1 in 4,000 live births |
| Deaths | Rare, depends on complications |
TeenScreen is a mental health and suicide risk screening program for teenagers. It was developed by the Division of Child and Adolescent Psychiatry at Columbia University. The program was designed to identify mental health issues in adolescents, including depression, anxiety, and suicidal ideation. The program has been implemented in schools, primary care clinics, and other community settings across the United States.
Overview[edit]
The TeenScreen program was developed in response to the high rates of undiagnosed mental health issues in adolescents. The program uses a two-step process to identify at-risk youth. First, a computerized questionnaire is administered to assess risk factors and symptoms. Those who score above a certain threshold are then interviewed by a mental health professional for further evaluation.
Effectiveness[edit]
Several studies have demonstrated the effectiveness of the TeenScreen program in identifying adolescents at risk for mental health issues and suicide. However, the program has also been criticized for potentially over-identifying at-risk youth and for not having a clear protocol for follow-up care.
Criticism[edit]
Critics of the TeenScreen program argue that it may lead to over-diagnosis of mental health issues and unnecessary medication of adolescents. There are also concerns about the lack of a clear protocol for follow-up care for those identified as at risk.
See also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
